June 1, 2019 Adding Ribociclib to First-Line Endocrine Therapy Significantly Improves Survival for Pre-Menopausal Women with Advanced Breast Cancer “Advanced breast cancer in pre-menopausal women can be very aggressive. It is important and encouraging to see a targeted therapy that significantly increases survival for younger women with this disease,” said ASCO Expert Harold J....
Pro zobrazení tohoto obsahu je třeba být přihlášen.